-
Hyponatremia, heart failure, and the role of tolvaptan.
Postgraduate medicine 20120301
-
The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.
Clinical and experimental nephrology 20120201
-
Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients.
Journal of intensive care medicine 20120101
-
Novel treatment targets for cerebral edema.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20120101
-
[Hyponatremic syndrome].
La Clinica terapeutica 20120101
-
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Wiadomosci lekarskie (Warsaw, Poland : 1960) 20120101
-
Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure.
Texas Heart Institute journal 20120101
-
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Journal of cardiac failure 20111201
-
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.
Journal of cardiac failure 20111201
-
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Current heart failure reports 20110901
-
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Kidney international 20110901
-
Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
Neurosurgery 20110801
-
The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
Journal of pharmacy practice 20110801
-
Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury.
Neurocritical care 20110601
-
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501
-
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
European journal of clinical pharmacology 20110401
-
Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110401
-
Hyponatremia: vasopressin antagonists in hyponatremia: more data needed.
Nature reviews. Nephrology 20110301
-
A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.
Neurocritical care 20110201
-
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure model.
American journal of therapeutics 20110101
-
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options.
Nephron. Clinical practice 20110101
-
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
Clinical cardiology 20101101
-
Extreme correction of hyponatremia in a patient treated with intravenous conivaptan.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20101001
-
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
Drug discovery today 20101001
-
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.
Neurocritical care 20100801
-
Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
Bioorganic & medicinal chemistry letters 20100615
-
Use of conivaptan for the treatment of symptomatic hyponatremia in a patient with acute decompensated heart failure.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100615
-
Sodium, potassium and glucose management in organ transplantation.
Current opinion in organ transplantation 20100601
-
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100501
-
The vaptans: just landed. But how was the trip?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100501
-
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Journal of cardiac failure 20100501
-
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100501
-
[Vasopressin receptor antagonists: the vaptans].
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20100501
-
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
The Annals of pharmacotherapy 20100401
-
Vasopressin receptor antagonist use in a neurologic rehabilitation center.
The journal of spinal cord medicine 20100201
-
Hyponatremia: evaluation and management.
Hospital practice (1995) 20100201
-
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.
Heart failure reviews 20100101
-
Novel agents for the treatment of hyponatremia: a review of conivaptan and tolvaptan.
Cardiology in review 20100101
-
Tolvaptan (Samsca) for hyponatremia.
The Medical letter on drugs and therapeutics 20091130
-
[Vasopressin receptor antagonists and heart failure].
Therapeutische Umschau. Revue therapeutique 20091101
-
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20091001
-
Conivaptan: promise of treatment in heart failure.
Expert opinion on pharmacotherapy 20090901
-
Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
Annals of oncology : official journal of the European Society for Medical Oncology 20090701
-
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Clinical therapeutics 20090701
-
Pharmacology of vasopressin antagonists.
Heart failure reviews 20090601
-
AVP receptor antagonists in patients with CHF.
Heart failure reviews 20090601
-
Hyponatremia: case vignettes.
Seminars in nephrology 20090501
-
Conivaptan for hyponatremia in the neurocritical care unit.
Neurocritical care 20090101
-
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
The American journal of the medical sciences 20090101
-
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
Neurocritical care 20090101
-
New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia.
Journal of pharmacological sciences 20090101
-
Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
Blood purification 20090101
-
Hyponatremia in heart failure.
Journal of intensive care medicine 20090101
-
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Journal of cardiac failure 20081001
-
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
Journal of cardiac failure 20081001
-
Use of conivaptan to allow aggressive hydration to prevent tumor lysis syndrome in a pediatric patient with large-cell lymphoma and SIADH.
Pediatric nephrology (Berlin, Germany) 20080801
-
[Etiology, diagnostics and therapy of hyponatremias].
Orvosi hetilap 20080720
-
Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
Clinical endocrinology 20080701
-
Conivaptan: potential therapeutic implications in heart failure.
Recent patents on cardiovascular drug discovery 20080601
-
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Current heart failure reports 20080601
-
Non-peptide arginine-vasopressin antagonists: the vaptans.
Lancet (London, England) 20080510
-
Vasopressin-receptor antagonists in heart failure.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080501
-
The management of ascites and hyponatremia in cirrhosis.
Seminars in liver disease 20080201
-
Hyponatremia in psychiatric patients: update on evaluation and management.
Harvard review of psychiatry 20080101
-
Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia.
International urology and nephrology 20080101
-
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
Progress in brain research 20080101
-
Intravenous conivaptan.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101
-
Hyponatremia and vasopressin antagonism in congestive heart failure.
Clinical cardiology 20071101
-
Current issues for nurse practitioners: Hyponatremia.
Journal of the American Academy of Nurse Practitioners 20071101
-
Hyponatremia: clinical diagnosis and management.
The American journal of medicine 20070801
-
[Vasopressin antagonists in treatment of hyponatremia].
Polskie Archiwum Medycyny Wewnetrznej 20070801
-
Conivaptan: new treatment for hyponatremia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701
-
Clinical practice. The syndrome of inappropriate antidiuresis.
The New England journal of medicine 20070517
-
New drugs 07, part I.
Nursing 20070201
-
Management of hyponatremia and clinical use of vasopressin antagonists.
The American journal of the medical sciences 20070201
-
Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Clinical therapeutics 20070201
-
[Arginine vasopressin antagonism--new treatment option in chronic heart failure].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070118
-
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Biological & pharmaceutical bulletin 20070101
-
Therapeutic potential of vasopressin receptor antagonists.
Drugs 20070101
-
Intravenous conivaptan: effects on the QTc interval and other electrocardiographic parameters in healthy volunteers.
Advances in therapy 20070101
-
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
American journal of nephrology 20070101
-
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Cardiovascular drug reviews 20070101
-
Vasopressin antagonists--progress and promise.
The New England journal of medicine 20061116
-
Excipient hydrolysis and ester formation increase pH in a parenteral solution over aging.
International journal of pharmaceutics 20061115
-
Molecule of the Month: Conivaptan hydrochloride.
Drug news & perspectives 20061101
-
Hyponatremia in cirrhosis: clinical features and management.
Gastroenterologie clinique et biologique 20061001
-
AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Cleveland Clinic journal of medicine 20060901
-
Vasopressin antagonists.
Cellular and molecular life sciences : CMLS 20060801
-
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
The American journal of medicine 20060701
-
Conivaptan (Vaprisol) for hyponatremia.
The Medical letter on drugs and therapeutics 20060619
-
Cardiac function and heart failure.
Journal of the American College of Cardiology 20060606
-
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
The Journal of clinical endocrinology and metabolism 20060601
-
Vasopressin receptor antagonists.
Kidney international 20060601
-
Conivaptan: a selective vasopressin antagonist.
Drugs of today (Barcelona, Spain : 1998) 20060601
-
Vasopressin receptor antagonists in heart failure.
Recent patents on cardiovascular drug discovery 20060601
-
Vasopressin excess and hyponatremia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 20060501
-
Vaptans and the treatment of water-retaining disorders.
Seminars in nephrology 20060501
-
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Autonomic & autacoid pharmacology 20060401
-
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Journal of the American Society of Nephrology : JASN 20060101
-
Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.
Expert review of cardiovascular therapy 20060101
-
New drugs: rasagiline mesylate, conivaptan hydrochloride, and sunitinib malate.
Journal of the American Pharmacists Association : JAPhA 20060101
-
New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval.
Heart advisor 20051001
-
Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
Pharmacological research 20050301
-
Conivaptan Yamanouchi.
Current opinion in investigational drugs (London, England : 2000) 20050301
-
Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
European journal of pharmacology 20050110
-
Vasopressin antagonists in heart failure.
Current heart failure reports 20041201
-
Conivaptan: YM 087.
Drugs in R&D 20040101
-
Vasopressin receptor antagonists in heart failure.
Current opinion in pharmacology 20031201
-
2,5-disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists.
Bioorganic & medicinal chemistry letters 20031117
-
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Clinical science (London, England : 1979) 20030701
-
Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
Journal of hepatology 20030601
-
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial.
American heart journal 20030101
-
Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs.
Pharmacological research 20021101
-
Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction.
European journal of pharmacology 20020823
-
[Treatment of heart failure: an update].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020701
-
Vasopressin antagonists in CHF: ready for clinical trials?
Cardiovascular research 20020401
-
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition.
Cardiovascular research 20020401
-
Body compartment volumes and composition after giving a vasopressin antagonist: changes are revealed by a tonicity balance.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020201
-
Conivaptan (Yamanouchi).
Current opinion in investigational drugs (London, England : 2000) 20020101
-
Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.
Journal of computer-aided molecular design 20011201
-
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
Circulation 20011113
-
Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide.
The American journal of medicine 20010501
-
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
British journal of pharmacology 19981201
-
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
Naunyn-Schmiedeberg's archives of pharmacology 19980101